Business Context and Reporting Period
Company: Protalix Biotherapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 13, 2010
Reporting Period: Single event date (September 13, 2010)
This filing serves as a Regulation FD disclosure regarding an upcoming corporate presentation. It does not contain periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event rather than a financial statement.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
- Event Announcement: Dr. David Aviezer, President and CEO, will present at the UBS Global Life Sciences Conference.
- Event Details: September 20, 2010, at 10:30 AM ET, held at the Grand Hyatt Hotel in New York City.
- Access: An audio webcast of the presentation will be available on the company website (www.protalix.com).
- Legal Status: The information is furnished pursuant to Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the date and time of the UBS Global Life Sciences Conference presentation (September 20, 2010).
- Confirm the availability of the audio webcast on the company website.
- Review the attached press release (Exhibit 99.1) for specific details on the presentation content.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.